A national survey on the management of psoriatic arthritis using the Delphi method

Ennio Lubrano, Fabrizio Cantini, Alessandro Mathieu, Ignazio Olivieri, Carlo Salvarani, Raffaele Scarpa, Antonio Marchesoni

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective Accurate diagnosis and appropriate management of psoriatic arthritis (PsA) is essential to avoid unnecessary morbidity. Our aim in this study was to evaluate the current approach to the management of PsA among rheumatologists. Methods A 16-item online questionnaire, produced using the Delphi method, was submitted to a panel of rheumatologists who anonymously expressed their opinions on a scale from 1 (maximum disagreement) to 5 (maximum agreement). Positive consensus was defined by ≥66% of the respondents scoring an item 3, 4 or 5. Negative consensus was defined by ≥66% of the respondents scoring an item 1 or 2. Results The surveyed rheumatologists agreed that in its early stage, PsA is characterised by the involvement of few joints and/or entheses and that psoriasis, although possibly absent, will be present in a patient's past personal or family history. There was no consensus among the rheumatologists regarding normalisation of C-reactive protein levels and erythrocyte sedimentation rates defining remission. The specialists believed that clinical remission was achieved more frequently and for longer among patients with PsA than rheumatoid arthritis. The participants believed that neutralising antibodies altered the efficacy of anti-tumour necrosis factor agents and that monoclonal antibodies induced greater production of neutralising antibodies than receptor proteins. However, knowledge was somewhat lacking in relation to the prophylaxis of latent tuberculosis. Conclusion The data collected showed that the surveyed rheumatologists had a good knowledge of the diagnosis of early-stage PsA and a good understanding of its management in relation to its clinical phenotype, with the exception of the form having predominantly axial involvement.

Original languageEnglish
Pages (from-to)214-220
Number of pages7
JournalClinical and Experimental Rheumatology
Volume35
Issue number2
Publication statusPublished - 2017

Fingerprint

Psoriatic Arthritis
Consensus
Neutralizing Antibodies
Latent Tuberculosis
Blood Sedimentation
Psoriasis
C-Reactive Protein
Rheumatoid Arthritis
Tumor Necrosis Factor-alpha
Joints
Monoclonal Antibodies
Rheumatologists
Surveys and Questionnaires
Morbidity
Phenotype
Proteins

Keywords

  • Delphi method
  • Disease management
  • Psoriatic arthritis
  • Spondyloarthritis
  • Survey

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Lubrano, E., Cantini, F., Mathieu, A., Olivieri, I., Salvarani, C., Scarpa, R., & Marchesoni, A. (2017). A national survey on the management of psoriatic arthritis using the Delphi method. Clinical and Experimental Rheumatology, 35(2), 214-220.

A national survey on the management of psoriatic arthritis using the Delphi method. / Lubrano, Ennio; Cantini, Fabrizio; Mathieu, Alessandro; Olivieri, Ignazio; Salvarani, Carlo; Scarpa, Raffaele; Marchesoni, Antonio.

In: Clinical and Experimental Rheumatology, Vol. 35, No. 2, 2017, p. 214-220.

Research output: Contribution to journalArticle

Lubrano, E, Cantini, F, Mathieu, A, Olivieri, I, Salvarani, C, Scarpa, R & Marchesoni, A 2017, 'A national survey on the management of psoriatic arthritis using the Delphi method', Clinical and Experimental Rheumatology, vol. 35, no. 2, pp. 214-220.
Lubrano, Ennio ; Cantini, Fabrizio ; Mathieu, Alessandro ; Olivieri, Ignazio ; Salvarani, Carlo ; Scarpa, Raffaele ; Marchesoni, Antonio. / A national survey on the management of psoriatic arthritis using the Delphi method. In: Clinical and Experimental Rheumatology. 2017 ; Vol. 35, No. 2. pp. 214-220.
@article{7b4696c30945436f885fa580eb550a67,
title = "A national survey on the management of psoriatic arthritis using the Delphi method",
abstract = "Objective Accurate diagnosis and appropriate management of psoriatic arthritis (PsA) is essential to avoid unnecessary morbidity. Our aim in this study was to evaluate the current approach to the management of PsA among rheumatologists. Methods A 16-item online questionnaire, produced using the Delphi method, was submitted to a panel of rheumatologists who anonymously expressed their opinions on a scale from 1 (maximum disagreement) to 5 (maximum agreement). Positive consensus was defined by ≥66{\%} of the respondents scoring an item 3, 4 or 5. Negative consensus was defined by ≥66{\%} of the respondents scoring an item 1 or 2. Results The surveyed rheumatologists agreed that in its early stage, PsA is characterised by the involvement of few joints and/or entheses and that psoriasis, although possibly absent, will be present in a patient's past personal or family history. There was no consensus among the rheumatologists regarding normalisation of C-reactive protein levels and erythrocyte sedimentation rates defining remission. The specialists believed that clinical remission was achieved more frequently and for longer among patients with PsA than rheumatoid arthritis. The participants believed that neutralising antibodies altered the efficacy of anti-tumour necrosis factor agents and that monoclonal antibodies induced greater production of neutralising antibodies than receptor proteins. However, knowledge was somewhat lacking in relation to the prophylaxis of latent tuberculosis. Conclusion The data collected showed that the surveyed rheumatologists had a good knowledge of the diagnosis of early-stage PsA and a good understanding of its management in relation to its clinical phenotype, with the exception of the form having predominantly axial involvement.",
keywords = "Delphi method, Disease management, Psoriatic arthritis, Spondyloarthritis, Survey",
author = "Ennio Lubrano and Fabrizio Cantini and Alessandro Mathieu and Ignazio Olivieri and Carlo Salvarani and Raffaele Scarpa and Antonio Marchesoni",
year = "2017",
language = "English",
volume = "35",
pages = "214--220",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "2",

}

TY - JOUR

T1 - A national survey on the management of psoriatic arthritis using the Delphi method

AU - Lubrano, Ennio

AU - Cantini, Fabrizio

AU - Mathieu, Alessandro

AU - Olivieri, Ignazio

AU - Salvarani, Carlo

AU - Scarpa, Raffaele

AU - Marchesoni, Antonio

PY - 2017

Y1 - 2017

N2 - Objective Accurate diagnosis and appropriate management of psoriatic arthritis (PsA) is essential to avoid unnecessary morbidity. Our aim in this study was to evaluate the current approach to the management of PsA among rheumatologists. Methods A 16-item online questionnaire, produced using the Delphi method, was submitted to a panel of rheumatologists who anonymously expressed their opinions on a scale from 1 (maximum disagreement) to 5 (maximum agreement). Positive consensus was defined by ≥66% of the respondents scoring an item 3, 4 or 5. Negative consensus was defined by ≥66% of the respondents scoring an item 1 or 2. Results The surveyed rheumatologists agreed that in its early stage, PsA is characterised by the involvement of few joints and/or entheses and that psoriasis, although possibly absent, will be present in a patient's past personal or family history. There was no consensus among the rheumatologists regarding normalisation of C-reactive protein levels and erythrocyte sedimentation rates defining remission. The specialists believed that clinical remission was achieved more frequently and for longer among patients with PsA than rheumatoid arthritis. The participants believed that neutralising antibodies altered the efficacy of anti-tumour necrosis factor agents and that monoclonal antibodies induced greater production of neutralising antibodies than receptor proteins. However, knowledge was somewhat lacking in relation to the prophylaxis of latent tuberculosis. Conclusion The data collected showed that the surveyed rheumatologists had a good knowledge of the diagnosis of early-stage PsA and a good understanding of its management in relation to its clinical phenotype, with the exception of the form having predominantly axial involvement.

AB - Objective Accurate diagnosis and appropriate management of psoriatic arthritis (PsA) is essential to avoid unnecessary morbidity. Our aim in this study was to evaluate the current approach to the management of PsA among rheumatologists. Methods A 16-item online questionnaire, produced using the Delphi method, was submitted to a panel of rheumatologists who anonymously expressed their opinions on a scale from 1 (maximum disagreement) to 5 (maximum agreement). Positive consensus was defined by ≥66% of the respondents scoring an item 3, 4 or 5. Negative consensus was defined by ≥66% of the respondents scoring an item 1 or 2. Results The surveyed rheumatologists agreed that in its early stage, PsA is characterised by the involvement of few joints and/or entheses and that psoriasis, although possibly absent, will be present in a patient's past personal or family history. There was no consensus among the rheumatologists regarding normalisation of C-reactive protein levels and erythrocyte sedimentation rates defining remission. The specialists believed that clinical remission was achieved more frequently and for longer among patients with PsA than rheumatoid arthritis. The participants believed that neutralising antibodies altered the efficacy of anti-tumour necrosis factor agents and that monoclonal antibodies induced greater production of neutralising antibodies than receptor proteins. However, knowledge was somewhat lacking in relation to the prophylaxis of latent tuberculosis. Conclusion The data collected showed that the surveyed rheumatologists had a good knowledge of the diagnosis of early-stage PsA and a good understanding of its management in relation to its clinical phenotype, with the exception of the form having predominantly axial involvement.

KW - Delphi method

KW - Disease management

KW - Psoriatic arthritis

KW - Spondyloarthritis

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=85018191422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018191422&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 214

EP - 220

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 2

ER -